Phase 1
Completed N=60
Chronic Resveratrol Supplementation in Healthy Humans
Healthy
Source: ClinicalTrials.gov NCT01640197 ↗
Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Oct 2012
Primary outcomePrimary: Chronic Modulation of Cerebral Blood Flow — 0; 0 Participants — p=>0.05
Summary
The effects of chronic resveratrol supplementation have yet to be investigated in healthy humans. It is hypothesised that the effects will be different to those seen in acute supplementation. This study will look specifically at cognitive performance, cerebral blood flow, subjective sleep, mood and health, blood pressure and plasma levels of resveratrol. It is hypothesized that these measures will be affected differently by acute and chronic supplementation.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Chronic Modulation of Cerebral Blood Flow |
0; 0 | >0.05 |
| SECONDARY Number of Participants With Modulated Mood |
0; 0 | >0.05 |
| SECONDARY Number of Participants With Modulated Cognitive Performance |
0; 0 | >0.05 |
| SECONDARY Number of Participants With Significant Modulation of Sleep |
0; 0 | >0.05 |
| SECONDARY Number of Participants With Significant Modulation of Health |
0; 0 | >0.05 |
| SECONDARY Number of Participants With Significant Modulation of Blood Pressure |
0; 0 | >0.05 |
| SECONDARY Number of Participants With Significant Modulation of CBF in MCA |
0; 0 | >0.05 |
Eligibility Criteria
Inclusion Criteria
- Healthy
- Between 18-35
- At least enrolled on undergraduate degree programme
- Native English speaker
Exclusion Criteria
- Smoking
- Taking other medication/ supplements
- Pregnant/ breast feeding
- High caffeine consumers
- Migraine sufferers
Data sourced from ClinicalTrials.gov (NCT01640197). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.